A Terpenoid-Rich Fraction of Inula viscosa: Its Chemical Composition, Antioxidant Capacity, and Anticancerous Effects Against Human Lung Cancer Cells
Author | Seglab, Fatiha |
Author | Abou Assali, Mazen |
Author | AlYafei, Thoraya |
Author | Hassan, Hassan |
Author | Pinto, Diana C.G.A |
Author | Baydoun, Safaa |
Author | Al Thani, Asmaa A. |
Author | Shaito, Abdullah A. |
Available date | 2024-09-08T07:32:50Z |
Publication Date | 2024 |
Identifier | http://dx.doi.org/10.20944/preprints202407.0755.v1 |
Citation | Seglab, F.; Abou Assali, M.; AlYafei, T.; Hassan, H.; Pinto, D.C.G.A.; Baydoun, S.; Al Thani, A.A.; Shaito, A.A. Chemical Composition, Antioxidant Capacity, and Anticancerous Effects against Human Lung Cancer Cells of a Terpenoid-Rich Fraction of Inula viscosa. Biology 2024, 13, 687. |
Abstract | Inula viscosa is a widely used plant in traditional Mediterranean and Middle Eastern medicine for various illnesses. I. viscosa has been shown to have anticancerous effects against various cancers, but its effects against lung cancer have been under limited investigation. At the same time, I. viscosa is rich in terpenoids whose anti-lung cancer effects have been poorly investigated. This study aimed to examine the potential anticancerous properties of methanolic and aqueous extracts of stems and leaves of I. viscosa and its terpenoid-rich fraction against human lung cancer A549 cells. Results showed a high radical scavenging capacity and polyphenol and flavonoid contents of I. viscosa methanolic rather than aqueous extracts. In addition, leaves methanolic extracts (IVLM) showed the highest reduction in viability of A549 cells among all the extracts. IVLM also reduced the viability of human ovarian SK-OV-3, breast MCF-7, liver HepG2, and colorectal HCT116 cancer cells. A terpenoid-rich I. viscosa fraction (IVL DCM), prepared by liquid-liquid separation of IVLM in dichloromethane (DCM), displayed a substantial reduction in the viability of A549 cells (IC50= 27.8 ± 1.5 µg/mL at 48 h) and the panel of tested cancerous cell lines but was not cytotoxic to normal human embryonic fibroblasts (HDFn). The assessment of IVL DCM phytochemical constituents using GC-MS analysis revealed 21 metabolites, highlighting an enrichment in terpenoids, such as lupeol and its derivatives, caryophyllene oxide, betulin, and isopulegol, known to exhibit proapoptotic, and antimetastatic functions. IVL DCM also showed robust antioxidant capacity and decent polyphenol and flavonoid contents. Furthermore, Western blotting analysis indicated that IVL DCM reduced proliferation (reduction of proliferation marker Ki67 and induction of proliferation inhibitor proteins P21 and P27), contaminant with P38 MAP kinase activation, and induced the intrinsic apoptotic pathway (P53/BCL2/BAX/ Caspase3/PARP) in A549 cells. IVL DCM also reduced the migration of A549 cells, potentially by reducing FAK activation. Future identification of anticancer metabolites of IVL DCM, especially terpenoids, is recommended. These data place I. viscosa as a new resource of herbal anticancer agents. |
Sponsor | This work was supported by Qatar University student grants QUST-2-BRC-2023-1588, QUST-1-BRC2024-1696, and QUST-1-BRC-2024-1697 to AS. |
Language | en |
Publisher | Preprints |
Subject | antioxidant capacity Inula viscosa Dittrichia viscosa A549 cells cytotoxic activity terpenoids dichloromethane |
Type | Article |
Volume Number | 1 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [738 items ]
-
Biomedical Sciences [738 items ]
-
Marine Science Cluster [214 items ]
-
Medicine Research [1508 items ]